menu
    • menu
    [{"orgOrder":0,"company":"MINT PHARMACEUTICALS INC","sponsor":"Bayer AG","pharmaFlowCategory":"D","therapeuticArea":"Cardiology\/Vascular Diseases","country":"CANADA","productType":"Miscellaneous","year":"2025","type":"Partnership","leadProduct":"Nifedipine","moa":"Voltage-gated L-type calcium channel","graph1":"Cardiology\/Vascular Diseases","graph2":"Approved FDF","graph3":"MINT PHARMACEUTICALS INC","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Tablet","sponsorNew":"MINT PHARMACEUTICALS INC \/ Bayer AG","highestDevelopmentStatusID":"15","companyTruncated":"MINT PHARMACEUTICALS INC \/ Bayer AG"}]

    Find Clinical Drug Pipeline Developments & Deals by MINT PHARMACEUTICALS INC

    Menu

    MINT PHARMACEUTICALS INC

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            MINT PHARMACEUTICALS INC

                            Canada arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            MINT PHARMACEUTICALS INC

                            Canada arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Nifedipine

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Approved FDF

                            Sponsor : Bayer AG

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            DEALS_DEV arrow-down

                            Mint Pharmaceuticals Announces Partnership with Bayer to Distribute Adalat XL in Canada

                            Details : The partnership aims to Distribute Adalat XL (nifedipine extended-release tablets), indicated for chronic stable angina and essential hypertension, in Canada.

                            Product Name : Adalat XL

                            Product Type : Miscellaneous

                            Upfront Cash : Undisclosed

                            September 25, 2025

                            Lead Product(s) : Nifedipine

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Approved FDF

                            Sponsor : Bayer AG

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth